Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Diana Rihawi

Establishing a Model for Assessing DNA Damage in Murine Brain Cells as a Molecular Marker of Chemotherapy-Associated Cognitive Impairment

Life Sciences

English

Related publications

Potential Role of pNF-H, a Biomarker of Axonal Damage in the Central Nervous System, as a Predictive Marker of Chemotherapy-Induced Cognitive Impairment

Clinical Cancer Research

Cancer Research

Oncology

2015

English

Filamin-A as a Marker and Target for DNA Damage Based Cancer Therapy

English

Frontal Atrophy as a Marker for Dementia Conversion in Parkinson's Disease With Mild Cognitive Impairment

Human Brain Mapping

Nuclear Medicine

Radiology

Ultrasound Technology

English

An Evaluation of DNA Methyltransferase 1 (DNMT1) Single Nucleotide Polymorphisms and Chemotherapy-Associated Cognitive Impairment: A Prospective, Longitudinal Study

Scientific Reports

Multidisciplinary

2019

English

The Long Amplicon Quantitative PCR for DNA Damage Assay as a Sensitive Method of Assessing DNA Damage in the Environmental Model, Atlantic Killifish (Fundulus Heteroclitus)

Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology

English

Brain Natriuretic Propeptide as a Marker of the Heart Damage in Metabolic Syndrome

Russian Journal of Cardiology

Cardiovascular Medicine

Cardiology

2015

English

Erratum To: S100B as a Marker for Brain Damage and Blood–Brain Barrier Disruption Following Exercise

English

Cognitive Change Questionnaire as a Method for Cognitive Impairment Screening

Dementia e Neuropsychologia

Cognitive Neuroscience

2015

English

Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment

Neural Plasticity

Neurology

2019

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Diana Rihawi

Establishing a Model for Assessing DNA Damage in Murine Brain Cells as a Molecular Marker of Chemotherapy-Associated Cognitive Impairment

Related publications

Potential Role of pNF-H, a Biomarker of Axonal Damage in the Central Nervous System, as a Predictive Marker of Chemotherapy-Induced Cognitive Impairment

Filamin-A as a Marker and Target for DNA Damage Based Cancer Therapy

Frontal Atrophy as a Marker for Dementia Conversion in Parkinson's Disease With Mild Cognitive Impairment

An Evaluation of DNA Methyltransferase 1 (DNMT1) Single Nucleotide Polymorphisms and Chemotherapy-Associated Cognitive Impairment: A Prospective, Longitudinal Study

The Long Amplicon Quantitative PCR for DNA Damage Assay as a Sensitive Method of Assessing DNA Damage in the Environmental Model, Atlantic Killifish (Fundulus Heteroclitus)

Brain Natriuretic Propeptide as a Marker of the Heart Damage in Metabolic Syndrome

Erratum To: S100B as a Marker for Brain Damage and Blood–Brain Barrier Disruption Following Exercise

Cognitive Change Questionnaire as a Method for Cognitive Impairment Screening

Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment